ALB and metabolic dysfunction-associated steatotic liver disease: Reduced albumin reflects impaired hepatic synthesis, malnutrition, and systemic disease, and is linked with advanced fibrosis and poor prognosis in metabolic dysfunction-associated steatotic liver disease (MASLD) (34).